UHS at a glance
Universal Health Services (UHS, SEC CIK 352915) filed its latest 10-K annual report on February 25, 2026, a 10-Q quarterly report on August 7, 2026, an 8-K current report on August 21, 2026 and Form 4 insider filings as recently as May 29, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), Universal Health Services (UHS) reported revenue of $17.4 billion (up 9.7% from FY2024) and net income of $1.5 billion. Diluted EPS was $23.10.
- As of June 30, 2026, 33 institutional investment managers tracked by SignalX reported holding Universal Health Services (UHS) shares worth $3.4 billion in 13F-HR filings.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $17.4B
- +9.7% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 33 funds
- $3.4B · +0 vs prior quarter
- Latest 8-K
- Aug 21, 2026
- Item 1.01
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Management Discussion & Analysis
- Revenue not explicitly stated as a total figure in the provided MD&A text; Medicaid legislative risk flagged at $432M–$480M annual net benefit reduction by 2032
- Share repurchases ~4.7 million shares at ~$899M aggregate cost in 2025; remaining buyback authorization ~$1.425B as of Dec 31, 2025
- $700M 1.65% senior notes maturing Sept 1, 2026; refinancing expected at materially higher interest rates, increasing interest expense
- Key risk: "One Big Beautiful Bill" Medicaid cuts estimated to reduce annual net benefit by $432M–$480M beginning 2028, phased through 2032
Business Overview
- Dual-segment operator: acute care hospitals (57% of revenue) and behavioral health facilities (43%), spanning 40 states, D.C., UK, and Puerto Rico
- UK behavioral health revenue grew to $1.001B in 2025 from $880M in 2024; total UK assets $1.531B vs $1.358B
- Outpatient behavioral health facility count methodology changed Q3 2025, driving majority of reported increase from 168 outpatient/other facilities total
- 101,500 total employees as of Dec 31, 2025; pending GWU Hospital physician group restructuring expected to absorb large number of physicians in Q2 2026
- "One Big Beautiful Budget Act" (July 4, 2025) estimated to reduce UHS annual net benefit by $432M–$480M by 2032 via Medicaid provider fee caps
Risk Factors
- One Big Beautiful Bill Act (July 4, 2025) to cut Medicaid provider fee threshold from 6% to 3.5% by 2032, reducing UHS net benefit by $432M–$480M annually
- UK behavioral health operations generated $1.001B revenue in 2025 with $1.531B total assets, exposed to pound sterling fluctuations and NHS contract dependency
- $700M senior notes at 1.65% mature September 1, 2026, requiring refinancing at materially higher market rates, increasing interest expense and reducing net income
- Excess commercial insurance renewed March 2025 with coverage exclusions for sexual abuse/molestation claims, higher premiums, and lower aggregate limits: heightened exposure given behavioral health patient population
- Ransomware and cybersecurity threats flagged as heightened risk; no insurance adequacy guarantee for potential breach costs across 375+ inpatient facilities
AI summary of the UHS 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- Revenue $4.638B, up 8.3% YoY from $4.284B
- Operating margin 11.1% vs 11.7% YoY
- Same-facility acute and behavioral health revenue up 7.8%, or $322M
- Net income attributable to UHS $358.447M vs $353.218M YoY
- Outlook headwinds: Medicaid reductions, expired exchange subsidies, staffing inflation, tariffs, higher interest expense
Risk Factors
- Newly added acquisition risk: Talkspace purchase for approximately $835 million requires regulatory approvals before expected third-quarter 2026 closing
- Most material transaction risk: Integration challenges could delay anticipated Talkspace synergies and increase merger-related costs
- Regulatory risk: District of Columbia OAG review could require unwinding or materially changing the CMG physician transition
- Operational risk: Physicians leaving District Hospitals could reduce patient volumes and revenues
- Financial risk: Talkspace acquisition financing requires additional borrowings under the amended Credit Agreement
AI summary of the UHS 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 1.01: Entry into a Material Definitive Agreement
- $1.1B senior secured notes issued: $600M at 5.500% due 2031 and $500M at 6.000% due 2036
- Annual interest expense of approximately $63M before refinancing effects
Item 2.03: Creation of a Direct Financial Obligation
- $400 million borrowed under delayed draw term loan facility for Talkspace acquisition
- Additional acquisition funding drawn under revolving credit facility
Item 8.01: Other Events
- UHS completed Talkspace acquisition on August 17, 2026, making it an indirect wholly owned subsidiary
- Talkspace shareholders received $5.25 cash per share, excluding cancelled shares
Item EX-99.1: Item EX-99.1
- UHS completed its acquisition of Talkspace on August 17, 2026, following regulatory approvals and customary closing conditions
- Combination creates an end-to-end behavioral healthcare platform spanning virtual, outpatient, crisis, inpatient and specialized care
Item 1.01: Entry into a Material Definitive Agreement
- $1.1B senior secured notes issuance: $600M at 5.500% due 2031 and $500M at 6.000% due 2036
- Senior secured guarantees from subsidiaries securing existing credit or other lien obligations
AI summaries of UHS 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for UHS
Don't miss the next UHS filing
- Alerts as it files. A push when UHS files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut UHS, by share count.
- Ask anything. An AI agent that reads every UHS filing and answers with sources.
UHS alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| MILLER ALAN B | J | May 27, 2026 | 14,163 | - |
| MILLER ALAN B | J | May 27, 2026 | 14,163 | - |
| MILLER ALAN B | J | May 27, 2026 | 9,418 | - |
| MILLER ALAN B | J | May 27, 2026 | 13,963 | - |
| MILLER ALAN B | J | May 27, 2026 | 9,418 | - |
| MILLER ALAN B | J | May 27, 2026 | 14,163 | - |
| MILLER ALAN B | J | May 27, 2026 | 9,418 | - |
| MILLER ALAN B | J | May 27, 2026 | 9,418 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $15.8B | $17.4B |
| Operating Income | $1.2B | $1.7B | $2.0B |
| Net Income | $717.8M | $1.1B | $1.5B |
| Op. Margin | - | 10.6% | 11.5% |
| Net Margin | - | 7.2% | 8.6% |
| Balance Sheet | |||
| Total Assets | - | $14.5B | $15.5B |
| Equity | - | $6.7B | $7.3B |
| ROE | - | 17.1% | 20.5% |
| Per Share | |||
| EPS | - | $16.82 | $23.10 |
| Cash Flow | |||
| Operating CF | $1.3B | $2.1B | $1.9B |
| CapEx | $743.1M | $943.8M | $1.0B |
Source: XBRL data in Universal Health Services (UHS)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate UHS share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 33 | $3.35B |
| Q1 2026 | 33 | $4.23B |
| Q4 2025 | 31 | $5.16B |
| Q3 2025 | 32 | $5.21B |
| Q2 2025 | 31 | $4.90B |
| Q1 2025 | 30 | $4.10B |
| Q4 2024 | 26 | $3.49B |
| Q3 2024 | 22 | $2.17B |
- Dimensional Fund Advisors+429.3K (+24%)
- Invesco Ltd+362.0K (+23%)
- Citadel Advisors LLC+226.0K (+275%)
- Morgan Stanley+132.2K (+21%)
- FMR LLC (Fidelity)+102.1K (+8%)
- Goldman Sachs Group−729.0K (-55%)
- State Street Corp−476.8K (-18%)
- BlackRock−285.3K (-7%)
- Millennium Management−270.4K (-39%)
- JPMorgan Chase & Co−133.4K (-40%)
- Mangrove Partners+7.1K
- Two Sigma Investments−155.8K
Source: 13F-HR filings on SEC EDGAR (aggregated from 238 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
UHS filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 8-K | Aug 21, 2026 | - | Analysis | - |
| 8-K | Aug 17, 2026 | - | Analysis | - |
| 8-K | Aug 13, 2026 | - | Analysis | - |
| 10-Q | Aug 7, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Jul 28, 2026 | - | Analysis | - |
| 8-K | Jul 21, 2026 | - | Analysis | - |
| 4 | May 29, 2026 | - | - | |
| 8-K | May 22, 2026 | - | Analysis | |
| 8-K | May 21, 2026 | - | Analysis | |
| 10-Q | May 7, 2026 | Mar 31, 2026 | Analysis | |
| SC 13G | Apr 30, 2026 | - | - | |
| 8-K | Apr 28, 2026 | - | Analysis | - |
| 8-K | Apr 24, 2026 | - | Analysis | - |
| 8-K | Mar 30, 2026 | - | - | - |
| 4 | Mar 30, 2026 | - | - | - |
| 4 | Mar 30, 2026 | - | - | - |
| 4 | Mar 30, 2026 | - | - | - |
| 4 | Mar 30, 2026 | - | - | - |
| 4 | Mar 30, 2026 | - | - | - |
| 4 | Mar 23, 2026 | - | - | - |
| 4 | Mar 23, 2026 | - | - | - |
| 4 | Mar 23, 2026 | - | - | - |
| 4 | Mar 23, 2026 | - | - | - |
| 4 | Mar 23, 2026 | - | - | - |
| 4 | Mar 13, 2026 | - | - | - |
Related Health Care companies
- ARDT · Ardent Health, Inc.Services-General Medical & Surgical Hospitals, NEC
- CYH · COMMUNITY HEALTH SYSTEMS INCServices-General Medical & Surgical Hospitals, NEC
- HCA · HCA HealthcareServices-General Medical & Surgical Hospitals, NEC
- SGRY · Surgery Partners, Inc.Services-General Medical & Surgical Hospitals, NEC
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
- ABT · Abbott LaboratoriesPharmaceutical Preparations
UHS SEC filings: frequently asked questions
Which institutions hold UHS stock?
As of June 30, 2026, the largest Universal Health Services (UHS) holders among the 13F filers tracked by SignalX were BlackRock ($603.7 million), Vanguard Capital Management LLC ($504.4 million), Vanguard Portfolio Management LLC ($364.6 million), Dimensional Fund Advisors ($328.7 million), State Street Corp ($312.6 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was UHS's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), Universal Health Services (UHS) reported revenue of $17.4 billion (up 9.7% from FY2024) and net income of $1.5 billion. Diluted EPS was $23.10. The figures come from the XBRL data in the 10-K.
What are the main risks in UHS's latest 10-K?
In the 10-K filed February 25, 2026, Universal Health Services (UHS) flagged: One Big Beautiful Bill Act (July 4, 2025) to cut Medicaid provider fee threshold from 6% to 3.5% by 2032, reducing UHS net benefit by $432M–$480M annually. UK behavioral health operations generated $1.001B revenue in 2025 with $1.531B total assets, exposed to pound sterling fluctuations and NHS contract dependency. (AI summary of the Risk Factors section.)
What did UHS report in its latest 8-K?
Universal Health Services (UHS) filed an 8-K on August 21, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement). $1.1B senior secured notes issued: $600M at 5.500% due 2031 and $500M at 6.000% due 2036.
What are the latest UHS SEC filings?
Universal Health Services (UHS) filed its latest 10-K annual report on February 25, 2026, a 10-Q quarterly report on August 7, 2026, an 8-K current report on August 21, 2026 and a Form 4 insider filing on May 29, 2026.
What is UHS's SEC CIK number?
Universal Health Services (UHS)'s SEC Central Index Key (CIK) is 352915. EDGAR lists every UHS filing under that number.
Ask anything about UHS
The research agent reads UHS's filings, financials, insider trades and 13F holders, then answers with sources.